Journal Mobile Options
Table of Contents
Vol. 13, No. 5-6, 2006
Issue release date: August 2007
Section title: Paper
Neuroimmunomodulation 2006;13:283–293
(DOI:10.1159/000104856)

Stress and Coping Strategies in Systemic Lupus Erythematosus: A Review

Bricou O. · Taïeb O. · Baubet T. · Gal B. · Guillevin L. · Moro M.R.
aDepartment of Psychiatry, Hôpital Avicenne (AP-HP), Paris 13 University, Bobigny, and bDepartment of Internal Medicine, Hôpital Cochin (AP-HP), Paris 5 University, Paris, France

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Paper

Received: 8/30/2006
Accepted: 10/30/2006
Published online: 8/22/2007

Number of Print Pages: 11
Number of Figures: 0
Number of Tables: 1

ISSN: 1021-7401 (Print)
eISSN: 1423-0216 (Online)

For additional information: http://www.karger.com/NIM

Abstract

Systemic lupus erythematosus (SLE), a chronic and unpredictable disease accompanied by functional disability and a possible involvement of the central nervous system, leads to considerable psychological distress. A review of studies on stress and/or coping strategies in SLE since 1990 is presented. Many studies have investigated the place of major and minor stress and coping strategies in SLE morbidity (disease activity, organ damage, and physical and mental components of quality of life). Stress as a causal factor is not proved, but it seems to act as an exacerbating factor in disease activity and to have an impact on the quality of life. Coping strategies are more consistently associated with quality of life than with disease activity. Organ damage appears to be less associated with psychosocial factors than disease activity or quality of life. Despite the limitations of these studies, therapeutic interventions should be proposed to reduce psychological distress, to improve the quality of life and possibly to moderate the evolution of the disease.


  

Author Contacts

Dr. Olivier Taïeb, MD
Department of Psychiatry (Pr. M. R. Moro)
Hôpital Avicenne (AP-HP), Paris 13 University, 125 Rue de Stalingrad
FR–93000 Bobigny (France)
Tel. +33 1 48 95 51 05, Fax +33 1 48 95 51 06, E-Mail olivier.taieb@avc.aphp.fr

  

Article Information

Published online: August 6, 2007
Number of Print Pages : 11
Number of Figures : 0, Number of Tables : 1, Number of References : 46

  

Publication Details

Neuroimmunomodulation

Vol. 13, No. 5-6, Year 2006 (Cover Date: August 2007)

Journal Editor: Savino, W. (Rio de Janeiro)
ISSN: 1021–7401 (print), 1423–0216 (Online)

For additional information: http://www.karger.com/NIM


Article / Publication Details

First-Page Preview
Abstract of Paper

Received: 8/30/2006
Accepted: 10/30/2006
Published online: 8/22/2007

Number of Print Pages: 11
Number of Figures: 0
Number of Tables: 1

ISSN: 1021-7401 (Print)
eISSN: 1423-0216 (Online)

For additional information: http://www.karger.com/NIM


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.